Cardiovascular adverse effects of sugammadex.
作者信息
Kapoor Mukul Chandra
机构信息
Department of Anaesthesiology, Max Smart Super Specialty Hospital, Saket, Delhi, India.
出版信息
J Anaesthesiol Clin Pharmacol. 2020 Oct-Dec;36(4):469-470. doi: 10.4103/joacp.JOACP_132_20. Epub 2020 Sep 29.
Abstract
摘要
相似文献
1
Cardiovascular adverse effects of sugammadex.舒更葡糖钠的心血管不良反应。
J Anaesthesiol Clin Pharmacol. 2020 Oct-Dec;36(4):469-470. doi: 10.4103/joacp.JOACP_132_20. Epub 2020 Sep 29.
2
Safety of sugammadex for reversal of neuromuscular block: A postmarketing study based on the World Health Organization pharmacovigilance database.舒更葡糖钠用于逆转神经肌肉阻滞的安全性：一项基于世界卫生组织药物警戒数据库的上市后研究。
Br J Clin Pharmacol. 2023 Feb;89(2):449-457. doi: 10.1111/bcp.15417. Epub 2022 Jun 8.
3
Adverse Effects of Sugammadex on the Cardiovascular System.舒更葡糖钠对心血管系统的不良反应
Cureus. 2023 Feb 7;15(2):e34728. doi: 10.7759/cureus.34728. eCollection 2023 Feb.
4
Is adamgammadex the brother of sugammadex or the next generation of reversal agent?阿曲库铵葡萄糖酸盐是罗库溴铵的兄弟还是新一代逆转剂？
Br J Anaesth. 2024 Jan;132(1):15-17. doi: 10.1016/j.bja.2023.11.006. Epub 2023 Nov 29.
5
Adverse events of sugammadex that occurred in a Korean population.在韩国人群中发生的舒更葡糖钠不良事件。
Anesth Pain Med (Seoul). 2022 Apr;17(2):191-198. doi: 10.17085/apm.21096. Epub 2022 Apr 5.
6
Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults.舒更葡糖钠与新斯的明在成人中逆转神经肌肉阻滞的疗效与安全性比较
Cochrane Database Syst Rev. 2017 Aug 14;8(8):CD012763. doi: 10.1002/14651858.CD012763.
7
Risk of bronchospasm and coronary arteriospasm with sugammadex use: a post marketing analysis.使用舒更葡糖钠后发生支气管痉挛和冠状动脉痉挛的风险：一项上市后分析。
Ther Adv Drug Saf. 2019 Aug 18;10:2042098619869077. doi: 10.1177/2042098619869077. eCollection 2019.
8
Estimated Incidence of Sugammadex-Induced Anaphylaxis Using the Korea Adverse Event Reporting System Database.利用韩国不良事件报告系统数据库估算舒更葡糖钠所致过敏反应的发生率。
J Clin Med. 2021 Jul 21;10(15):3202. doi: 10.3390/jcm10153202.
9
Bradycardia in a pediatric population after sugammadex administration: case series.舒更葡糖钠给药后儿科人群的心动过缓：病例系列。
Braz J Anesthesiol. 2023 Jan-Feb;73(1):101-103. doi: 10.1016/j.bjane.2021.12.011. Epub 2022 Feb 1.
10
Sugammadex in the management of rocuronium-induced anaphylaxis.苏伽 苷 钠 在 罗 库 溴 铵 诱 发 过 敏 反 应 中 的 应 用。
Br J Anaesth. 2011 Feb;106(2):199-201. doi: 10.1093/bja/aeq366. Epub 2010 Dec 10.
引用本文的文献
1
A review of recent advances in anesthetic drugs for patients undergoing cardiac surgery.心脏手术患者麻醉药物的最新进展综述。
Front Pharmacol. 2025 Feb 18;16:1533162. doi: 10.3389/fphar.2025.1533162. eCollection 2025.
2
Asystolic cardiac arrest secondary to sugammadex administration in a young patient.一名年轻患者在使用舒更葡糖钠后发生心搏停止性心脏骤停。
Anaesthesiol Intensive Ther. 2024;56(2):160-163. doi: 10.5114/ait.2024.141235.
3
Conventional reversal of rocuronium-induced neuromuscular blockade by sugammadex in Korean children: pharmacokinetics, efficacy, and safety analyses.在韩国儿童中使用舒更葡糖钠常规逆转罗库溴铵诱导的神经肌肉阻滞：药代动力学、疗效及安全性分析
Front Pharmacol. 2023 Apr 13;14:1127932. doi: 10.3389/fphar.2023.1127932. eCollection 2023.
4
Sugammadex administration in patients with end-stage renal disease: a narrative review with recommendations.终末期肾病患者使用舒更葡糖钠：一项带建议的叙述性综述
Anesth Pain Med (Seoul). 2023 Jan;18(1):11-20. doi: 10.17085/apm.22259. Epub 2023 Jan 25.
5
Sugammadex to Facilitate Neurologic Assessment in Severely Brain-Injured Patients: A Retrospective Analysis and Practical Guidance.舒更葡糖钠用于促进重度脑损伤患者的神经功能评估：一项回顾性分析及实用指南
Cureus. 2022 Oct 19;14(10):e30466. doi: 10.7759/cureus.30466. eCollection 2022 Oct.
6
Reversal of rocuronium-induced intense neuromuscular blockade by sugammadex in Korean children: A pharmacokinetic and pharmacodynamic analysis.罗库溴铵诱导的韩国儿童重度神经肌肉阻滞的逆转：药代动力学和药效学分析。
Clin Transl Sci. 2023 Jan;16(1):92-103. doi: 10.1111/cts.13429. Epub 2022 Oct 17.
本文引用的文献
1
Decrease in heart rate following the administration of sugammadex in adults.成人使用舒更葡糖钠后心率下降。
J Anaesthesiol Clin Pharmacol. 2020 Oct-Dec;36(4):465-469. doi: 10.4103/joacp.JOACP_346_19. Epub 2021 Jan 18.
2
Heart rate changes following the administration of sugammadex in children: a prospective, observational study.舒更葡糖钠用于儿童给药后的心率变化：一项前瞻性观察性研究。
J Anesth. 2020 Apr;34(2):238-242. doi: 10.1007/s00540-019-02729-y. Epub 2020 Jan 24.
3
Profound Bradycardia and Cardiac Arrest After Sugammadex Administration in a Previously Healthy Patient: A Case Report.在一名既往健康的患者中使用舒更葡糖钠后出现严重心动过缓和心脏骤停：一例病例报告
A A Pract. 2019 Jan 1;12(1):22-24. doi: 10.1213/XAA.0000000000000834.
4
Severe bradycardia and asystole after sugammadex.使用舒更葡糖钠后出现严重心动过缓和心搏停止。
Br J Anaesth. 2018 Jul;121(1):95-96. doi: 10.1016/j.bja.2018.02.036. Epub 2018 Mar 28.
5
Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials.舒更葡糖钠与新斯的明逆转神经肌肉阻滞作用的疗效和安全性的Meta 分析：随机对照试验。
J Clin Anesth. 2016 Dec;35:1-12. doi: 10.1016/j.jclinane.2016.06.018. Epub 2016 Aug 4.
6
Cardiac arrest after sugammadex administration in a patient with variant angina: a case report.一例变异型心绞痛患者使用舒更葡糖钠后发生心脏骤停：病例报告
Korean J Anesthesiol. 2016 Oct;69(5):514-517. doi: 10.4097/kjae.2016.69.5.514. Epub 2016 Jul 25.
7
8
Transient third-degree AV block following sugammadex.
J Anesth. 2015 Aug;29(4):641. doi: 10.1007/s00540-015-1980-5. Epub 2015 Feb 12.
9
Sugammadex: a novel selective relaxant binding agent.苏伽达非：一种新型选择性松弛剂结合剂。
Expert Rev Clin Pharmacol. 2009 Jan;2(1):37-53. doi: 10.1586/17512433.2.1.37.
10
A case of atrioventricular block (Wenckebach type) induced by sugammadex.一例由舒更葡糖钠诱发的房室传导阻滞（文氏型）。
J Anesth. 2012 Aug;26(4):627-8. doi: 10.1007/s00540-012-1390-x. Epub 2012 Apr 19.
Zotero 插件